Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Skip to main content

Contracts Grants Pricing Blog Glossary

Loading...

Kontrakk

The only workspace built for the work of government contracting.

Platform

Discovery feed
Pursuit board
Grants

Industries

Federal contractors
Defense primes
Nonprofit grants
Higher education

Resources

Help center
Developer docs

Company

About
Privacy
Terms of Service

© 2026 Kontrakk. All rights reserved.Government Contracts. Won with Confidence.

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Home
Grants
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

posted

synopsis

#PA-24-253

Agency

National Institutes of Health

Code: HHS-NIH11

Description

No description available

Important Dates

Open Date

Jul 11, 2024

Close Date

Jul 17, 2027

CFDA Numbers

93.213

93.866

93.396

93.398

93.352

93.310

93.867

93.855

93.837

93.233

93.846

93.393

93.350

93.859

93.853

93.353

93.399

93.351

93.397

93.839

93.286

93.113

93.840

93.121

93.172

93.879

93.395

93.847

93.865

93.394

93.143

93.173

93.361

93.273

93.279

93.838

93.242

93.307

93.142

View on Grants.gov

More grants from National Institutes of Health

Investigator-Focused Award (Parent R35)
National Institutes of Health
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)
National Institutes of Health
Clinical and Translational Science Award
National Institutes of Health
Limited Competition: Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards Program
National Institutes of Health